Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2018-12-12 | 2019-10-08 | 69444 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-05-30 | 2024-09-27 | 229161 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2021-06-18 | 2022-01-10 | 141234 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2021-10-15 | 2022-02-19 | 147289 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-04-12 | 2024-10-04 | 225101 |
| APO-APREMILAST | 30MG | TABLET | Resolved | 2025-01-24 | 2025-01-31 | 248558 |
| APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2025-02-13 | 2025-04-17 | 250307 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2025-02-13 | 2025-03-07 | 250313 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2025-02-13 | 2025-04-11 | 250322 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2025-01-16 | 2025-01-31 | 247894 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Actual shortage | 2025-04-04 | 2025-04-17 | 254159 |
| APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126234 |
| APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126239 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126242 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126245 |
| APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126248 |
| APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126251 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126254 |
| APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126257 |
| APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126260 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |